Stable growth hormone compounds

Details for Australian Patent Application No. 2010207725 (hide)

Owner Novo Nordisk Health Care AG

Inventors Olsen, Ole Hvilsted; Breinholt, Jens; Schiodt, Christine Bruun; Demuth, Helle; Norskov-Lauritsen, Leif; Thygesen, Peter

Agent Shelston IP

Pub. Number AU-A-2010207725

PCT Pub. Number WO2010/084173

Priority 09151108.9 22.01.09 EP; 61/148,119 29.01.09 US

Filing date 22 January 2010

Wipo publication date 29 July 2010

International Classifications

C07K 14/61 (2006.01) Peptides having more than 20 amino acids

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/084173 Priority application(s): WO2010/084173

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010207729-Compressor, in particular a radial piston compressor for carbon dioxide as a refrigerant

2010207721-FGF21 derivatives with albumin binder A-B-C-D-Eand their use